SLN   $18.425  0.68% Market Open

Silence Therapeutics PLC
Total Cash 149.59M
totalCashPerShare 1.066
EBITDA -48.16M
Total Debt 184.00K
quickRatio 9.148
currentRatio 9.83
Total Revenue 17.90M
debtToEquity 0.164
Revenue/Share 0.429
ROA -0.21538
ROE -0.64282
grossProfits
freeCashflow -14.30M
operatingCashflow -29.05M
earningsGrowth
revenueGrowth -0.934
grossMargins 0.56404996
ebitdaMargins -2.69024
operatingMargins -30.64047
profitMargins -2.2401
enterpriseValue 2.47B
forwardPE
floatShares 78.75M
sharesOutstanding 46.80M
sharesShort 254.63K
sharesShortPriorMonth 561.16K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.17%
heldPercentInstitutions 0.60%
Short Ratio help_outline 0.94%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.404
Price To Book help_outline 7.69
earningsQuarterlyGrowth
netIncomeToCommon -40.10M
trailingEps -1.28%
forwardEps
enterpriseToEbitda -51.38
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 80
lastUpdated Sept. 16, 2024, 8:24 p.m.